We are live on ! Find out more
GCM

Glenview Capital Management Portfolio holdings

AUM $3.98B
1-Year Est. Return 20.52%
This Fund
S&P 500
This Quarter Est. Return
+3.24%
1 Year Est. Return
+20.52%
3 Year Est. Return
+68.18%
5 Year Est. Return
+87.14%
10 Year Est. Return
+400.35%
AUM
$15.3B
AUM Growth
+$1.3B
Cap. Flow
+$866M
Cap. Flow %
5.67%
Top 10 Hldgs %
42.05%
Holding
87
New
20
Increased
18
Reduced
21
Closed
19

Top Buys

Rank Stock Value
1
ELV icon
Elevance Health
ELV
+$383M
2
HRI icon
Herc Holdings
HRI
+$356M
3
EBAY icon
eBay
EBAY
+$298M
4
MON
Monsanto Co
MON
+$266M
5
AET
Aetna Inc
AET
+$251M

Sector Composition

Rank Sector Weight
1 Healthcare 36.39%
2 Consumer Discretionary 11.02%
3 Financials 9.85%
4 Technology 8.22%
5 Industrials 7.53%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PSX icon
26
Phillips 66
PSX
$84.9B
$187M 1.23%
2,432,481
FIS icon
27
Fidelity National Information Services
FIS
$23.1B
$185M 1.21%
3,460,785
-1,521,800
-31% -$81.2M
BWXT icon
28
BWX Technologies
BWXT
$15.5B
$183M 1.2%
7,717,810
-9,926
-0.1% -$240K
CI icon
29
Cigna
CI
$73.8B
$172M 1.13%
2,060,010
-634,500
-24% -$52.3M
GM icon
30
General Motors
GM
$80.4B
$170M 1.11%
4,942,667
-1,400,000
-22% -$51.4M
AON icon
31
Aon
AON
$76.5B
$165M 1.08%
1,956,444
+21,287
+1% +$1.77M
ADT
32
DELISTED
ADT Corp
ADT
$163M 1.06%
5,426,697
+336,400
+7% +$11.1M
AMT icon
33
American Tower
AMT
$80.8B
$146M 0.96%
1,782,711
EA icon
34
Electronic Arts
EA
$53B
$140M 0.92%
4,816,091
-3,140,100
-39% -$84.2M
UNH icon
35
UnitedHealth
UNH
$376B
$139M 0.91%
+1,692,631
New +$127M
AAP icon
36
Advance Auto Parts
AAP
$3.35B
$136M 0.89%
1,073,303
-1,244,050
-54% -$151M
ENDP
37
DELISTED
Endo International plc
ENDP
$135M 0.88%
+1,964,201
New +$139M
FNF icon
38
Fidelity National Financial
FNF
$13.9B
$127M 0.83%
7,049,987
-116,558
-2% -$2.1M
CRI icon
39
Carter's
CRI
$1.42B
$121M 0.79%
1,553,829
+500,000
+47% +$36M
MTOR
40
DELISTED
MERITOR, Inc.
MTOR
$119M 0.78%
9,737,854
PNR icon
41
Pentair
PNR
$10.4B
$114M 0.75%
2,147,260
-3,658,128
-63% -$191M
DGX icon
42
Quest Diagnostics
DGX
$25.7B
$113M 0.74%
+1,951,300
New +$105M
S
43
DELISTED
Sprint Corporation
S
$112M 0.74%
+12,208,867
New +$107M
LH icon
44
Labcorp
LH
$25.4B
$105M 0.69%
+1,249,169
New +$99.6M
CAR icon
45
Avis
CAR
$4.86B
$105M 0.69%
+2,155,542
New +$92.6M
EVTC icon
46
Evertec
EVTC
$1.88B
$104M 0.68%
4,214,400
-199,600
-5% -$4.94M
GPN icon
47
Global Payments
GPN
$23B
$103M 0.68%
2,900,560
+214,200
+8% +$7.36M
MSFT icon
48
Microsoft
MSFT
$3.45T
$102M 0.67%
2,487,967
-2,774,000
-53% -$104M
NXPI icon
49
NXP Semiconductors
NXPI
$57.8B
$82.5M 0.54%
1,403,020
-753,600
-35% -$39.3M
JCP
50
DELISTED
J.C. Penney Company, Inc.
JCP
$80.8M 0.53%
9,370,487
-3,000,000
-24% -$21.7M

Similar funds

Glenview Capital Management's Q1 2014 Portfolio in Review

As of Q1 2014, Glenview Capital Management held 87 positions worth $15.3B, up 9.3% from $14B the previous quarter. Its ten largest holdings account for 42% of the portfolio.

Glenview Capital Management deployed $866M of net new capital in Q1 2014, opening 20 new positions and adding to 18 existing holdings. Its largest new stake was Elevance Health: 4,231,950 shares worth $421M.

By sector, the portfolio is most concentrated in Healthcare at 36% of assets, up from 33% a quarter earlier, followed by Consumer Discretionary and Financials.

On the sell side, the largest reduction was Pentair, an estimated $191M trimmed.

  • Glenview Capital Management's largest Q1 2014 buy was Elevance Health: 4,231,950 shares worth $421M.
  • Glenview Capital Management added most to Monsanto Co in Q1 2014, an estimated $266M increase.
  • Glenview Capital Management's biggest Q1 2014 reduction was Pentair, cutting an estimated $191M.
  • Glenview Capital Management fully exited HEALTH MGMT ASSOC INC CL-A in Q1 2014, selling an estimated $495M.
  • Glenview Capital Management's ten largest holdings make up 42% of its $15.3B portfolio in Q1 2014.
  • Glenview Capital Management opened 20 new positions and closed 19 in Q1 2014.
  • Glenview Capital Management's portfolio value rose 9.3% quarter-over-quarter to $15.3B.

Based on Glenview Capital Management's 13F filing for Q1 2014, filed 15 May 2014.